Is Acromicric Dysplasia contagious?

Acromicric dysplasia is not a contagious disease and cannot be spread through physical contact, respiratory droplets, or any other form of person-to-person interaction. It is a rare genetic skeletal disorder caused by specific mutations in the FBN2 gene, meaning it is present from birth and cannot be transmitted to others.

What is the cause of Acromicric dysplasia?

Acromicric dysplasia is a genetic condition caused by heterozygous mutations in the FBN2 gene, which provides instructions for making fibrillin-2, a protein essential for the formation of elastic fibers in connective tissue. Because Acromicric dysplasia is rooted in the body’s genetic code, it is biologically impossible for it to be infectious or communicable. It is classified as a skeletal dysplasia, characterized by short stature, short hands and feet, and distinct facial features.

Why is there confusion regarding the contagion of Acromicric dysplasia?

Rare conditions like Acromicric dysplasia are often misunderstood by the public because their physical presentation—such as short stature or unique facial structure—is unfamiliar to most people. When a condition is rare, the lack of general awareness can lead to unfounded fears or social stigma. It is important to emphasize that living with, touching, or caring for someone with Acromicric dysplasia poses absolutely no risk of transmission to family members, friends, or caregivers.

Are there environmental triggers for Acromicric dysplasia?

There are no environmental triggers for Acromicric dysplasia. Unlike infectious diseases, which rely on external pathogens (bacteria or viruses), the development of Acromicric dysplasia is determined entirely by an individual's DNA. The following facts clarify the nature of the condition:

• Genetic Origin: It is typically caused by a de novo (new) mutation, meaning it is not usually inherited from parents.


• Non-Communicable: There is no risk of catching the condition, regardless of how much time is spent in close proximity to an affected individual.


• Biological Stability: The symptoms of Acromicric dysplasia remain consistent with the genetic mutation and do not fluctuate based on exposure to germs or environmental toxins.

Next steps

• Consult a clinical geneticist to discuss the specific FBN2 mutation and its implications.


• Connect with the 3 community members on DiseaseMaps.org to share experiences and reduce isolation.


• Educate family and peers by sharing reputable resources from the NIH GARD or Orphanet.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Acromicric dysplasia overview.


• Orphanet: Rare disease database (ORPHA:93278).


• OMIM (Online Mendelian Inheritance in Man): FBN2-related skeletal dysplasias entry #102370.